OBJECTIVE -Delayed gastric emptying and/or gastrointestinal symptoms occur in 30 -50% of diabetic patients. Known contributing factors are autonomic neuropathy and acute hyperglycemia, but the role of gastric autoimmunity has never been investigated, although 15-20% of type 1 diabetic patients exhibit parietal cell antibodies (PCAs). We studied gastric motility in diabetes in relation to PCA status, autonomic nerve function, HbA 1c , thyroidstimulating hormone (TSH), Helicobacter pylori (HP), acid production, and gastric histology.
CONCLUSIONS -We found that ϳ50% of type 1 diabetic patients studied had delayed gastric emptying that did not correlate with symptoms. Gastric autoimmunity did not contribute to diabetic gastroparesis. Metabolic control was worse in patients with delayed solid emptying.
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A s many as 30 -50% of type 1 diabetic patients have evidence of del a y e d g a s t r i c e m p t y i n g , a dysfunction that may be manifested in gastrointestinal symptoms and/or metabolic instability (1) (2) (3) (4) . Conversely, many patients with gastroparesis are asymptomatic, and subjects with symptoms may have normal gastric emptying (4, 5) . Diabetic gastroparesis comprises a decrease in fundic and antral motor activity (6 -8) , a reduction in or lack of the interdigestive migrating motor complex (8) , gastric dysrhythmias (9) , and "pylorospasms" (10) . The etiology of diabetic gastroparesis is still not fully established, but important factors seem to be autonomic neuropathy (6, (11) (12) (13) , acute hyperglycemia (14, 15) , and abnormalities of gut hormones and neurotransmitters, such as motilin (16) , gastrin (17) , and nitric oxide (18) . Thyroid function (19) , gastric acid secretion (20, 21) , or Helicobacter pylori (HP) infection (22) may also modulate gastrointestinal motility. However, the role of gastric autoimmunity in diabetic gastroparesis has never been investigated, although 15-20% of type 1 diabetic patients exhibit parietal cell antibodies (PCAs) (23) , which, by impairing acid secretion (24, 25) , may modify gastric motility. Because treatment is possible (1, 2, 26) , diagnosing and identifying risk factors for gastroparesis is important for controlling symptoms and enhancing glucoregulation.
We examined the prevalence of delayed gastric emptying, under euglycemic conditions, in type 1 diabetic patients in relation to PCA status, cardiovascular autonomic function, HbA 1c , HP status, thyroid function, acid production, gastrin levels, and gastric histology. The relationship between gastric emptying and gastrointestinal symptoms was also evaluated. We are one of the first to perform the 13 Coctanoic acid breath test (13, 27, 28) and the first to use the 13 C-glycine breath test for solid and liquid emptying, respectively, in diabetic patients.
RESEARCH DESIGN AND METHODS

Patients
We studied 42 euthyroidic type 1 diabetic patients, comprising 15 PCAϩ and 27 PCAϪ subjects (male/female 29/13; mean age 40 Ϯ 15 years; mean diabetes duration 18 Ϯ 9 years; mean HbA 1c 7.8 Ϯ 0.9%). The patients were consecutively recruited, regardless of gastrointestinal symptoms, from 69 PCAϩ and 100 PCAϪ patients attending the Antwerp University Diabetes Clinic, and fulfilled criteria for type 1 diabetes (29) . Patients with a history of gastric surgery or gastric outlet obstruction or who were taking motility-altering drugs, anti-inflammatory drugs, antacids, or proton pump inhibitors were excluded. Smoking, drinking beverages containing alcohol or caffeine, and strenuous exercise were prohibited in the 24 h before the gastric emptying tests. The local ethics committee approved the study, and each patient gave written informed consent.
Methods
PCAs were assayed by indirect immunofluorescence (Medical Diagnostics California, Carlsbad, CA; Nl Ͻ1/20 dilution) (23) . Gastrin was measured by radioimmunoassay (Euro-Diagnostics, Malmö , Sweden; Nl Ͻ110 ng/l). Thyroid peroxidase antibodies were assayed by radiobinding assay (Henningtest, Brahms, Germany; Nl Ͻ100 units/ml). Thyroid function was estimated by assay of thyroidstimulating hormone (TSH) (Nl 0.47-4.7 mU/l) and free T4 levels (fT4) (Nl 10.8 -21.9 pmol/l) (Vitros; Ortho Clinical Diagnostics, Amersham, Amersham, U.K.). Gastrointestinal symptoms. Gastrointestinal symptoms were assessed by questionnaire. Anorexia, nausea, early satiety, abdominal bloating/fullness, vomiting, abdominal pain, dysphagia, heartburn, and acid regurgitation were graded as 0 ϭ none, 1 ϭ mild (the symptom could be ignored), 2 ϭ moderate (the symptom could not be ignored, but did not influence daily activities), and 3 ϭ severe (the symptom influenced daily activities) (3). Reproducibility of this questionnaire was measured by a test-retest procedure, and validity was documented by comparing questionnaire data with an independent interview. The reproducibility and validity were high in this study (coefficients of variation [CVs] 4.8 and 9.5%, respectively). Autonomic nerve function. Autonomic nerve function was documented by standardized cardiovascular reflex tests (30) . Parasympathetic function was evaluated by the variation of heart rate (RϪR interval) during deep breathing and the immediate heart rate response to standing (30:15 ratio) and the Valsalva maneuver. Sympathetic function was assessed by the fall in systolic blood pressure in response to standing. The results were classified as follows: 0 ϭ normal; 1 ϭ borderline cardiovascular autonomic neuropathy (CAN; one abnormal heart rate test), 2 ϭ definite CAN (Ն2 abnormal heart rate tests), and 3 ϭ severe CAN (all abnormal heart rate and blood pressure tests). The reproducibility, expressed as the CV for autonomic neuropathy test, was 2.4% for heart rate variability, 9.5% for the deep breathing test and Valsalva maneuver, and 7.1% for the heart rate response to standing and for the postural blood pressure test. Helicobacter pylori. HP IgG antibodies were assayed by enzyme-linked immunosorbent assay (Roche Diagnostics, Brussels, Belgium). Urea breath tests, using 75 g 13 C-urea, were performed after a 12-h overnight fast (31) . Antrum, corpus, and fundus biopsies were examined for HP colonization by a modified Giemsa stain and/or immunostaining. HP infection was diagnosed if any test was positive. The period between the urea breath test and gastroscopy was Յ14 days.
At upper gastrointestinal endoscopy (Olympus Videoscope GIF/Q140; Melville, NY), at least two biopsies from fundus, corpus, antrum, and descending duodenum were taken. Then, two investigators evaluated 5-m sections, unaware of the patient's clinical and laboratory findings. The visual analog scale of the updated Sydney system was used to evaluate inflammation, activity, atrophy, intestinal metaplasia, and HP colonization (32) . HP immunostaining was performed by standard procedures using a polyclonal rabbit HP IgG antibody (Dako B0471; Dako, Glostrup, Denmark; dilution 1/200). Gastric acid secretion. Gastric acid secretion was studied in euglycemic conditions after a 12-h overnight fast using pentagastrin-stimulated acid output (6 g/kg body wt., s.c.) (Pentagastrin Injection BP; Cambridge Laboratories, Newcastle Upon Tyne, UK). Gastric juice was collected for 1 h before and 1 h after pentagastrin administration in 15-min aliquots. Hypochlorhydria was defined as a maximal acid output Ͻ15 mmol H ϩ /h.
Gastric emptying
To eliminate the effect of acute hyperglycemia on gastric emptying, patients' blood glucose levels were stabilized in the euglycemic range. Patients received their standard morning insulin dose at least 30 min before the test meal. At 15-min intervals, glycemia was tested by fingerstick (One Touch blood glucose meter; Lifescan, Milpitas, CA) to maintain glycemia at 4.5-6 mmol/l for at least 30 min before and at 4.5-8 mmol/l after the test meal. One intravenous cannula was inserted into antecubital vein for infusion of glucose 5% buffered with 10 units shortacting insulin at 50 ml/h (Human Actrapid; Novo Nordisk, Copenhagen, Denmark) to maintain euglycemia. If glycemia exceeded Ն 7 mmol/l, intravenous short-acting insulin was given: 1 unit for glycemia Ն7 mmol/l, 2 units for glycemia Ն8 mmol/l, and 3 units for glycemia Ն9 mmol/l. If glycemia was Ͻ3.5 mmol/l, 20% glucose in 10-ml aliquots was given to normalize levels: 1 ampulla of 10 ml glucose 20% for glycemia Ͻ3.5 mmol/l and 2 ampullae for glycemia Ͻ2.5 mmol/l. To avoid 14 C, we used two 13 C breath tests, which were performed within an 8-to 24-day period.
C octanoic acid breath test (solids)
The test was performed after a 12-h overnight fast. Patients avoided 13 C-rich meals 48 h before the breath test to increase its accuracy. Baseline breath 13 CO 2 before eating the test meal was measured. The test meal consisted of a beaten egg with the yolk doped with 100 mg of 13 Coctanoic acid (Isotec, Miamisburg, OH), two slices of white bread, and 5 g margarine (33, 34) . The yolk was baked separately from the egg white to ensure firm labeling. The meal, with a caloric value of 250 kcal (42% carbohydrates, 18% protein, and 40% fat), was ingested in 10 min, and patients were allowed to drink 150 ml water in this period. Breath samples were collected over a 4-h period at 15-min intervals. 13 CO 2 measurements were performed with an isotope ratio mass spectrometer (Finnigan MAT-250; Finnigan, Bremen, Germany). Mathematical analysis of the excretion rate of 13 CO 2 allowed the definition of the gastricemptying coefficient (GEC) and the gastric half-emptying time (t 1/2 ). With a cutoff value for t 1/2breathsolids of 75 min and a cutoff value for GEC breathsolids of 3.1 min, excellent sensitivity, specificity, and positive and negative predictive values were obtained to separate normal subjects from patients with delayed gastric emptying (33,34).
C-glycine breath test (liquids)
We chose 100 mg of 13 C-glycine as the marker of the liquid phase because it is easily solubilized in water and is rapidly absorbed and converted into 13 CO 2 after it enters the small intestine. Cutoff values for the GEC breathliquids and t 1/2breathliquids were 3 and 55Ј, respectively (34) .
Good-to-excellent correlations between the GEC and the scintigraphic halfemptying time (r ϭ 0.74 for liquids, r ϭ 0.88 for solids) and between the t 1/2 determined by breath test and scintigraphy (r ϭ 0.91 for liquids, r ϭ 0.92 for solids) have been previously described (33, 34) .
Statistical analysis
Results were statistically analyzed using SPSS software (SPSS, Chicago, IL). The unpaired t test or Mann-Whitney U test was used to determine differences between groups. Differences in distributions of categorical data were investigated by 2 or Fisher's exact test. The Pearson or Spearman rank correlation test was used.
Stepwise forward logistic regression analysis was used to assess the strength and independence of associations. A twotailed P Ͻ 0.05 was considered significant.
RESULTS -Gastrointestinal symptoms were reported by 43% of patients, but the majority of patients had no or only mild symptoms, with a median symptom score of 4. Early satiety and abdominal bloating were present in 17 patients (33%), nausea and/or vomiting in 7 patients (17%), abdominal pain in 6 patients, and regurgitation and/or heartburn in 5 patients. No associations were noted between presence or score of symptoms and indexes of solid and liquid emptying (GEC and t 1/2 ). Autonomic neuropathy was present in seven patients (three severe, two definite, and two borderline).
Parietal cell antibody findings Sex, age, diabetes duration, HbA 1c , and presence and severity of gastrointestinal symptoms were similar in PCAϩ and PCAϪ diabetic subjects (Table 1) . PCAϩ patients were more prone to having hypochlorhydria (odds ratio 12.1 [2.7-54.3], P ϭ 0.0008) and higher gastrin levels (P ϭ 0.003) than PCAϪ subjects. However, no differences were found in the prevalence of autonomic neuropathy, gastrointestinal complaints, HP infection, or delayed solid and liquid gastric emptying between PCAϩ and PCAϪ subjects (Table 1) .
Solid gastric emptying
Solid gastric emptying was delayed (GEC breathsolids Ͻ3.1, t 1/2breathsolids Ͼ75Ј) in 40% of type 1 diabetic patients. The mean glycemia during solid emptying was 119 Ϯ 37 mg/dl. In this range, glycemia did not correlate with indexes of solid emptying (GEC and t 1/2 ). However, patients with delayed solid emptying had higher HbA 1c levels than those with normal solid emptying (P ϭ 0.005) ( Table 2) . Autonomic neuropathy was equally common in both groups, and no association was observed between CAN score and rate of solid emptying. No differences were found in gastric histology (i.e., absence/presence of autoimmune gastritis), acid secretion parameters (basal, maximal, or peak acid output), or gastrin levels between those with and without gastroparesis. HbA 1c level (␤ ϭ 1.34;P ϭ 0.011) was the only independent risk factor for delayed solid gastric emptying in a logistic regression model testing HbA 1c , autonomic nerve function, PCA, HP status, gastrin, TSH, age, sex, and diabetes duration. The t 1/2breathsolid correlated strongly with GEC breathsolid (r ϭ Ϫ0.81, P Ͻ 0.0001). Patients with delayed solid emptying tended to have a delay in liquid emptying (P ϭ 0.1); furthermore, a correlation between t 1/2breathsolid and t 1/2breathliquid (r ϭ 0.44, P ϭ 0.037) was found. Solid and/or liquid emptying was delayed in 23 patients (55%).
Liquid gastric emptying
Liquid gastric emptying was delayed (GEC breathliquids Ͻ3, t 1/2breathliquids Ͼ55Ј) in 36% of type 1 diabetic patients. The mean glycemia during liquid emptying was 129 Ϯ 34 mg/dl. No correlations were observed between the level of glycemia and indexes of liquid emptying (GEC and t 1/2 ). Although each subject was euthyroidic, patients with delayed liquid emptying had higher TSH levels (P ϭ 0.02) than those with normal liquid emptying (Table 3) . Further, a strong correlation was noted between t 1/2breathliquid on one hand and TSH levels (r ϭ 0.83, P Ͻ 0.0001), fT4 levels (r ϭ Ϫ0.65, P ϭ 0.021), and CAN score (r ϭ Ϫ0.79, P ϭ 0.001) on the other. However, logistic regression analysis could not identify a single independent risk factor for liquid gastric emptying when HbA 1c , autonomic nerve function, PCA and HP infection status, gastrin and TSH levels, age, sex, and duration of diabetes were tested.
CONCLUSIONS -This study investigated the putative role of PCA, present in 15-20% of type 1 diabetic patients (23) , in the etiology of diabetic gastroparesis, using breath tests for liquid and solid emptying in euglycemic conditions. More than half of our type 1 diabetic patients (55%) had delayed gastric emptying (solids in 40% and liquids in 36%), in line with previous data (1-3). HbA 1c level was identified as a risk factor for delayed solid emptying. Autonomic nerve function, PCA or HP status, gastric histology, acid secretion, or gastrin or TSH level did not seem to affect solid emptying. On the other hand, TSH level and autonomic neuropathy score correlated with t 1/2breathliquid . Age, sex, and diabetes duration did not correlate with gastric emptying rate, supporting results from other studies (13, 35, 36) . Breath tests have several advantages over scintigraphy, with which they correlate very well (see RE-SEARCH DESIGN AND METHODS). They are easy to perform, noninvasive, have good reproducibility, and avoid radiation burden, thereby facilitating emptying studies i n f e r t i l e w o m e n a n d c h i l d r e n (13, 27, 28, 33, 34) . Moreover, many tests can be done simultaneously because 13 CO 2 can be analyzed overnight. Unlike a number of studies, ours controlled for many variables that may affect gastrointestinal symptoms and emptying: glucose level at the time of gastric emptying, gastric mucosal status, HP status, and autonomic nerve function. Most patients had no or only minor complaints, reflecting the fact that they were not selected on the basis of symptoms. We observed no association between gastric motility and symptoms, confirming some (7, 37) , but opposing other reports (4,13,38 ). In line with recent data (38) , bloating was the most common symptom. Abnormalities in visceral sensation (39) or a variable degree of vagal afferent and efferent dysfunction (1) might explain the poor link between symptoms and gastric motility. Glycemic control may also influence the prevalence or perception of gastrointestinal symptoms (15, 40) , although this was not supported by our results.
Gastric neuromuscular dysfunction may account for poor metabolic control, resulting from the dyssynchrony of insulin administration and emptying of nutrients (2,3). All our patients had good metabolic control. Nevertheless, we found that HbA 1c levels were associated with delayed solid emptying, contrary to findings in other studies (12, 13) . It is not clear whether worse metabolic control determines or is determined by delayed gastric emptying. Prospective follow-up studies designed to see whether improving HbA 1c would also improve gastric motility may help to clarify this interesting finding. Acute hyperglycemia may slow down gastric emptying (14, 15) by evoking pyloric contractions (41) or suppressing antral contractions (42) . In contrast, others found no link between glycemia and gastric motility (4, 6) . In euglycemic conditions, we did not see an effect of glucose levels on gastric emptying.
Autonomic neuropathy with loss of vagal tone and increased sympathetic nervous system activity has been associated with gastric dysrhythmias (5, 43) . Years ago, Kassander (5) noted the similarity between clinical and radiographic findings of gastroparesis and gastric atony observed after surgical vagotomy. In addition, some (44), but not all (45), researchers have found histologic abnormalities in vagal nerve tissue of diabetic patients. We did not observe a link between CAN scores and rates of solid emptying, confirming results from some studies (4, 27, 37) , but opposing results from other studies, describing a weak association (6, 12, 13) . However, a good correlation was found with t 1/2breathliquid . Perhaps these conflicting results are caused by differences in neuropathic involvement in solid and liquid emptying (4) or by differences in accuracy between classical CAN tests and the new ones using spectral and vector analysis (46) . Our approach in which breath tests were performed on 2 days to avoid the use of 14 C (21) . Moreover, one group observed a delay in gastric emptying in patients with chronic atrophic gastritis and hypoor achlorhydria (20) . However, others have reported that interdigestive antroduodenal motility in achlorhydria is not different from that in normal acidsecreting control subjects (21) . Our results support the observation that acid secretion is not essential in the regulation of gastric motility (47) . Moreover, we did not observe a link between gastric motility and PCA positivity, the latter being associated with hypochlorhydria, or gastric histology. Furthermore, HP infection did not influence gastric emptying or the presence or severity of gastrointestinal symptoms (22) . This is an important observation, because abnormal gastric emptying could affect urea breath test results. We and others have found no association between urea breath test and gastric emptying breath test results (22) .
Despite the fact that all patients were euthyroidic, we observed a strong correlation between t 1/2breathliquid and TSH levels. Thus subclinical hypothyroidism may affect gastric motor activity, as does overt hypothyroidism (19) . The pathogenesis of gastric motor hypoactivity is not precisely known. Autonomic neuropathy, disturbance of impulse conduction at the myoneural junction, changes in gastrointestinal peptide hormone metabolism, and autoimmune factors might explain this dysfunction.
In conclusion, more than half of type 1 diabetic patients studied had a delay in gastric emptying that did not correlate with symptoms. Gastric autoimmunity did not contribute to diabetic gastroparesis. HbA 1c level was the only independent risk factor for delayed solid emptying. Autonomic nerve function, PCA or HP infection status, age, sex, diabetes duration, gastric histology, gastrin levels, and acid secretion did not seem to affect solid emptying. On the other hand, TSH level and autonomic neuropathy score were correlated with t 1/2breathliquid . It is important to report the lack of contribution of gastric autoimmunity to delayed gastric emptying and to propose an etiological role of HbA 1c and subclinical hypothyroidism. It is hoped this work will stimulate new hypotheses and encourage the use of breath tests.
